Niraj Mehta is a Partner at ARTIS Ventures.

Niraj is focused on on sourcing, diligencing, and supporting companies in the therapeutics space.

Niraj currently holds 5 board seats across the ARTIS portfolios. Previously an ARTIS Fellow, he holds a PhD from Stanford University in Chemistry, where, under the mentorship of Dr. Elizabeth Sattely, he contributed to multiple scientific publications in top-tier journals, including a first-author publication in Cell. Niraj has vast experience in therapeutic drug development and genetic drug markets; before joining ARTIS, he led business development eMorts at Emcure Pharmaceuticals, a large multinational generic drug company. Niraj completed his undergraduate studies with a BS in Chemical Engineering from UCLA.

‍

Investments & Boards

OverT, Delix, and Pi Bio